Milestone Scientific announced that it has commenced sales of CompuFlo Epidural disposables into Island Ambulatory Surgery Center, a multi-specialty ambulatory surgery center based in Brooklyn, New York with a focus on pain management, orthopedics and spine care, urology, podiatry and plastic surgery. Island Ambulatory Surgery Center is affiliated with Mount Sinai Health System, MSHS, which operates 19 hospitals across New York. Adoption of the technology by this center follows a successful evaluation process by its founder and medical director, Dr. Leon Reyfman, MD, MBA, an interventional pain medicine physician, who is board-certified by the American Board of Anesthesiology in both anesthesiology and pain medicine. Arjan Haverhals, CEO and president of Milestone Scientific, stated, “We are proud to announce the adoption of our technology by Island Ambulatory Surgery Center, following a successful evaluation period. Moreover, this marks an important milestone as it represents the first commercial adoption of the CompuFlo(R) Epidural System within an ambulatory surgery center.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MLSS:
- Milestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference Call
- Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Island Ambulatory Surgery Center in Brooklyn, New York
- Milestone Scientific files $45M mixed securities shelf
- Milestone Scientific Appoints Pain Management Industry Veteran Dr. Didier Demesmin to its Board of Directors
